Skip to main content
Premium Trial:

Request an Annual Quote

Illinois Team Takes On Brain Cancer With a Multi-MicroRNA Approach


To help glioblastoma multiforme patients, researchers at the University of Illinois at Urbana-Champaign have taken an unusual approach to studying the role of microRNAs in this deadly brain cancer. By evaluating 534 miRNAs simultaneously — instead of one at a time as is typically done — the team confirmed 25 miRNAs previously associated with glioblastoma survival and found 20 miRNAs associated with breast cancer, ovarian cancer, and gastric adenocarcinoma tumor growth.

"If you look at one microRNA alone, it may appear to be related to cancer, but the relationship may be indirect — through another microRNA. So only by looking at all microRNAs can we truly find the association between each microRNA, taking into account all others," says Sandra Rodriguez Zas at Urbana-Champaign. "The challenge comes from the number of patients with survival and microRNA information relative to the number of microRNAs — you need to have many patients, observations, per microRNA in order to accurately and precisely conclude if the microRNA is associated with survival."

To meet these challenges, Zas and her group developed a bioinformatics pipeline that allows them to look at all miRNAs, remove those that are not associated with the disease, and still look at multiple miRNAs to establish which ones are related to cancer survival.

The researchers hope that drug therapies capable of boosting or repressing expression of the target genes, or the miRNAs that control the expression of those target genes, can be developed based on their lists of miRNAs. "One especially helpful aspect of our study is, because we are studying multiple microRNAs and their target genes, that the chances to develop an effective drug therapy based on our results increase. We are looking at the whole picture and the therapy development process can consider all components and their synergistic and antagonistic interactions," Zas says.

She and Kristin Delfino, a doctoral candidate at Urbana-Champaign, are now extending this approach to ovarian cancer survival. The extension includes the consideration of transcription factors, the identification of interaction between miRNAs, transcription factors, and gene targets for the development of additional therapies to fight this disease.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.